Article
ADAM29 Expression in Human Breast Cancer and its Effects on Breast Cancer Cells In Vitro.
Anticancer research - 1 Mar 2016
Zhao Meng, Jia Wang, Jiang Wen G, Wang Pilin, DU Guifang, Cheng Shan, Song Maomin
Abstract excerpt
BACKGROUND: A Disintegrin and Metalloprotease Domain 29 (ADAM29) is involved in many important physiological processes. Recent studies have demonstrated that ADAM29 is a susceptibility locus showing traits as a risk factor for breast cancer under genome-wide significance, however, the clinical relevance and cellular function of ADAM29 in breast cancer have not been reported. MATERIALS AND METHODS: In this study,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
